
Sign up to save your podcasts
Or


Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. The most recent edition, published this month, ranks each pharma based on their total revenues for 2023.
This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Senior Writer Kevin Dunleavy break down the numbers, highlight key trends and share some of the biggest changes at the top and bottom of the rankings year over year.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
By Fierce Life Sciences4.1
1212 ratings
Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. The most recent edition, published this month, ranks each pharma based on their total revenues for 2023.
This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Senior Writer Kevin Dunleavy break down the numbers, highlight key trends and share some of the biggest changes at the top and bottom of the rankings year over year.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.

3,217 Listeners

1,720 Listeners

4,345 Listeners

2,201 Listeners

406 Listeners

1,967 Listeners

353 Listeners

1,657 Listeners

145 Listeners

96 Listeners

3,976 Listeners

1,425 Listeners

337 Listeners

34 Listeners

170 Listeners